Brendan Smith - Insider Trading & Ownership

Location
29 Hartwell Avenue, Lexington, MA
Summary
The estimated net worth of Brendan Smith is at least $317K dollars as of February 22, 2023. Brendan Smith is the Chief Financial Officer of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $317K.
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Brendan Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG Chief Financial Officer $317K Feb 18, 2023
TBIO Translate Bio, Inc. Chief Financial Officer Sep 14, 2021

Insider Transactions Reported by Brendan Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.